Clinical Trials on ER Positive Breast Cancer in Norway
Total 191 results
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Oslo University HospitalBristol-Myers Squibb; Helse Stavanger HF; Sorlandet Hospital HF; Cliniques universitaires... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive TumorNorway, Belgium
-
Oslo University HospitalNorwegian Cancer Society; KlinbeforskActive, not recruitingBreast Cancer | Breast Neoplasms | Hormone Receptor Positive TumorNorway
-
Vestre Viken Hospital TrustRecruiting
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
University of BergenHaukeland University HospitalActive, not recruitingStage III Breast Cancer AJCC V7Norway
-
Oslo University HospitalCompletedBreast Cancer SurgeryNorway
-
Oslo University HospitalHologic, Inc.; Cancer Registry of NorwayUnknownRecall Rate | Cancer Detection Rate | False Positive Rate | Positive Predictive ValueNorway
-
Oslo University HospitalActive, not recruiting
-
Norwegian School of Sport SciencesUppsala University; Haukeland University Hospital; University of Agder; Norwegian... and other collaboratorsCompleted
-
Cancer Registry of NorwayRecruitingHealth, Subjective | Breast Cancer PatientsNorway
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
Norwegian School of Sport SciencesUniversity of Oslo; Memorial Sloan Kettering Cancer Center; Oslo University HospitalCompleted
-
IpsenTerminated
-
Oslo University HospitalTerminated
-
Nordlandssykehuset HFCompleted
-
Vestre Viken Hospital TrustOslo University HospitalActive, not recruiting
-
Oslo University HospitalActive, not recruitingBreast CancerNorway
-
University Hospital of North NorwayCompleted
-
Torbjorn OmlandOslo University Hospital; Novartis; University Hospital of North Norway; Helse... and other collaboratorsActive, not recruitingHeart Failure | Breast Cancer FemaleNorway
-
Hoffmann-La RocheNorwegian Radium HospitalCompleted
-
Oslo University HospitalUllevaal University Hospital; University of Tromso; Helse Stavanger HF; Sorlandet... and other collaboratorsCompletedBreast CancerNorway
-
University Hospital of North NorwayNorwegian Cancer SocietyTerminated
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
University Hospital, AkershusUniversity of Oslo; AstraZeneca; Norwegian Cancer SocietyCompletedHeart Failure | Breast CancerNorway
-
Oslo University HospitalThe Research Council of Norway; St. Olavs HospitalActive, not recruitingStage I Breast Cancer | Stage II Breast Cancer | DCIS Grade 3 | LCIS, Lobular Carcinoma in SituNorway
-
Cancer Registry of NorwayExtrastiftelsenCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityCompleted
-
Haukeland University HospitalActive, not recruitingLocally Advanced Breast Cancer | Metastatic Breast CarcinomaNorway
-
Ullevaal University HospitalThe Royal Norwegian Ministry of HealthCompletedDepression | Quality of Life | Breast Cancer | Anxiety | CopingNorway
-
University Hospital of North NorwayUniversity of TromsoCompleted
-
University Hospital, AkershusNorwegian Cancer Society; Helse Sor-Ost; ChromaDex, Inc.; Norwegian Breast Cancer...RecruitingHeart Failure | Breast Cancer | Metastatic Breast Cancer | Cardiotoxicity | Cancer Therapy-Related Cardiac DysfunctionNorway
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Helse Stavanger HFHelse-Bergen HFEnrolling by invitation
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
University of OsloOslo University HospitalCompletedPain, Postoperative | Breast Cancer | FatigueNorway
-
Sykehuset TelemarkUniversity of Oslo; Ohio State UniversityRecruitingBreast Cancer | Secondary LymphedemaNorway
-
Sykehuset TelemarkM.D. Anderson Cancer Center; Karolinska Institutet; Oslo University Hospital; University... and other collaboratorsActive, not recruiting
-
Lytix Biopharma ASICON plc; TheradexCompletedMelanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast CancerUnited Kingdom, France, Norway, Belgium, Italy
-
Sykehuset TelemarkCompletedBreast Cancer | MammaplastyNorway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
BayerCompletedBreast Cancer | Bone MetastasesBelgium, United Kingdom, Norway